Literature DB >> 1563538

Predictive value of testing random urine sample to detect microalbuminuria in diabetic subjects during outpatient visit.

B Bouhanick1, G Berrut, A M Chameau, M Hallar, F Bled, B Chevet, J Vergely, V Rohmer, P Fressinaud, M Marre.   

Abstract

The predictive value of random urine sample during outpatient visit to predict persistent microalbuminuria was studied in 76 Type 1, insulin-dependent diabetic subjects, 61 Type 2, non-insulin-dependent diabetic subjects, and 72 Type 2, insulin-treated diabetic subjects. Seventy-six patients attended outpatient clinic during morning, and 133 during afternoon. Microalbuminuria was suspected if Urinary Albumin Excretion (UAE) exceeded 20 mg/l. All patients were hospitalized within 6 months following outpatient visit, and persistent microalbuminuria was assessed then if UAE was between 30 and 300 mg/24 h on 2-3 occasions in 3 urines samples. Of these 209 subjects eighty-three were also screened with Microbumintest (Ames-Bayer), a semi-quantitative method. Among the 209 subjects, 71 were positive both for microalbuminuria during outpatient visit and a persistent microalbuminuria during hospitalization: sensitivity 91.0%, specificity 83.2%, concordance 86.1%, and positive predictive value 76.3% (chi-squared test: 191; p less than 10(-4)). Data were not different for subjects examined on morning, or on afternoon. Among the 83 subjects also screened with Microbumintest, 22 displayed both a positive reaction and a persistent microalbuminuria: sensitivity 76%, specificity 81%, concordance 80%, and positive predictive value 69% (chi-squared test: 126; p less than 10(-4)). Both types of screening appeared equally effective during outpatient visit. Hence, a persistent microalbuminuria can be predicted during an outpatient visit in a diabetic clinic.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1563538

Source DB:  PubMed          Journal:  Diabete Metab        ISSN: 0338-1684


  5 in total

Review 1.  Complications of diabetes: renal disease and promotion of self-management.

Authors:  A Melville; R Richardson; D Lister-Sharp; A McIntosh
Journal:  Qual Health Care       Date:  2000-12

Review 2.  Simulation modelling for immunologists.

Authors:  Andreas Handel; Nicole L La Gruta; Paul G Thomas
Journal:  Nat Rev Immunol       Date:  2019-12-05       Impact factor: 53.106

3.  Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.

Authors:  M Marre; X Jeunemaitre; Y Gallois; M Rodier; G Chatellier; C Sert; L Dusselier; Z Kahal; L Chaillous; S Halimi; A Muller; H Sackmann; B Bauduceau; F Bled; P Passa; F Alhenc-Gelas
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

4.  Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects.

Authors:  S Hadjadj; R Aubert; F Fumeron; F Pean; J Tichet; R Roussel; M Marre
Journal:  Diabetologia       Date:  2005-05-05       Impact factor: 10.122

5.  Effects of exenatide on urinary albumin in overweight/obese patients with T2DM: a randomized clinical trial.

Authors:  Chao Kang; Qiao Qiao; Qiang Tong; Qian Bai; Chen Huang; Rong Fan; Hui Wang; Kanakaraju Kaliannan; Jian Wang; Jing Xu
Journal:  Sci Rep       Date:  2021-10-08       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.